Clinical Cancer Research
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Clinical Cancer Research
Sep 14, 2024, 17:46 |
Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 9, 2024, 14:35 |
Blog
A three-year $200,000 grant for cancer research - Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation shared the following on LinkedIn: “Cancer research takes dedication and…
Aug 29, 2024, 02:52 |
Insight
Analysis of cfDNA Reveals Stemness Linked to Poor Survival in Lethal Prostate Cancer
Pradeep Chauhan, Radiation Oncologist at Mayo Clinic, shared a post about his latest paper on…
Aug 28, 2024, 11:11 |
Blog
MD Anderson Research Highlights
Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a…
Aug 18, 2024, 06:12 |
Blog
Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC
Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…
Aug 17, 2024, 08:07 |
Insight
Liang Cheng: An exciting time to study bladder cancer
Liang Cheng shared on LinkedIn: "I am very happy to know that our collaborative research…
Aug 16, 2024, 19:45 |
Insight
Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma
Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…
Aug 10, 2024, 14:33 |
Insight
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…
Aug 10, 2024, 11:52 |
Insight
Ahmad Ozair: Work from Adult Brain Tumor Consortium
Ahmad Ozair, Postdoctoral Research Fellow in Neurosurgery at University of Maryland, shared a post on…
Aug 8, 2024, 19:43 |
Insight
Alejandro Bertolet: Radiation-induced brain necrosis in proton therapy
Alejandro Bertolet, Assistant Professor of Radiation Oncology at Mass General Cancer Center, shared a post…
Aug 7, 2024, 14:42 |
Insight
Ibrahim Chamseddine: Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis
Ibrahim Chamseddine, Instructor in Radiation Oncology at Harvard Medical School, shared on X: "Excited to…
Jul 31, 2024, 17:01 |
Insight
Sequential Sacituzumab and Talazoparib for triple-negative breast cancer
Clinical Cancer Research shared a post on X about a recent paper by Aditya Bardia…
Jul 30, 2024, 13:23 |
Insight
Treatment of CML in pregnant patients and patients who are breastfeeding
FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…
Jul 25, 2024, 08:28 |
Blog
Recommendations to improve using Overall Survival data to inform benefit-risk assessments - FDA Oncology
FDA Oncology posted on X about recent paper by Lisa Rodriguez et al., commenting: "In…
Jul 25, 2024, 06:32 |
Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 25, 2024, 00:46 |
Blog
FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories
AACR posted on X/Twitter about recent paper by Timil Patel et al., commenting: "A Clinical Cancer…
Jul 25, 2024, 00:17 |
Blog
How to improve collection and analysis of Overall Survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared on LinkedIn: "A recent perspective paper in Clinical…
Jul 24, 2024, 07:43 |
Blog
Considerations to improve collection and analysis of overall survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared a post on LinkedIn: ''A new perspective paper…
Jul 18, 2024, 22:39 |
Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 14, 2024, 06:26 |
Insight
Daniele Marinelli: NRF2-driven transcription in NSCLC
Daniele Marinelli, PhD student at the Sapienza University of Rome, shared a post on X…
Jul 13, 2024, 11:33 |
Blog
Desert Horse-Grant: New K12 scholars of Sylvester Comprehensive Cancer Center
Desert Horse-Grant, Chief Transformation Officer at the Sylvester Comprehensive Cancer Center, shared a post on…
Jul 6, 2024, 15:02 |
Blog
FDA-AACR Oncology Educational Fellowship's impact on participants
American Association for Cancer Research shared a post on LinkedIn: “An article in Clinical Cancer…
Jul 1, 2024, 12:51 |
Blog
Career Development Beyond the FDA-AACR Oncology Educational Fellowship
FDA Oncology posted on X: "Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship…
Jun 28, 2024, 12:15 |
Insight
Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling
Talal El Zarif, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: .…
May 30, 2024, 02:01 |
Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 26, 2024, 15:35 |
Insight
Sumanta Pal: A massive effort to characterize the activity of Debio1347 by Petros Grivas and colleagues
Petros Grivas shared a post by Sumanta Pal on X/Twitter: "Thanks Sumanta Pal for highlighting our work with…
May 14, 2024, 15:36 |
Insight
Andy Hahn: Congrats to Ana Aparicio and team on this trial of 192 men with mCRPC
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Congratulations to…
May 8, 2024, 07:02 |
Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 3, 2024, 05:31 |
Blog
Francesco Maura: New papers on early intervention in smoldering myeloma
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center shared a thread on X: “New paper…
Apr 27, 2024, 07:10 |
Insight
,
Opinion
Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research
Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared…
Apr 16, 2024, 01:52 |
Insight
,
Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 12, 2024, 07:30 |
Blog
Urvi Shah: Grateful that our paper was selected for the inaugural Clinical Cancer Research early career award
Urvi Shah, Hematologist-oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X: "Thank…
Dec 23, 2023, 04:00 |
Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 9, 2023, 17:16 |
Insight
Vivek Subbiah: Finding the genomic fusion needles in the haystacks via Liquid Biopsy Precision Medicine
Vivek Subbiah, shared a post by Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and New…
Nov 25, 2023, 10:48 |
Blog
Nominations for the inaugural Clinical Cancer Research Early Career Award are now open - AACR Journals
AACR Journals shared a post on LinkedIn: "Nominations for the inaugural Clinical Cancer Research Early…
Oct 14, 2023, 21:53 |
Opinion
Biljana Naumovic: Building equitable access should be an all-encompassing priority – not an afterthought or a last step.
Biljana Naumovic, Worldwide Vice President Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson…
Jun 26, 2023, 19:45 |
Stories
NCRI is winding down after 22 remarkable years
In a post by NCRI Partnership on Twitter, it says, "Important news: NCRI is winding…
Jun 24, 2023, 18:25 |
Drugs
Still no role for targeting PI3K pathway in mCRPC - Arun Azad
Now online Clinical Cancer Research- Phase IB study ipatasertib plus ipatasertib in mCR prostate cancer…
May 28, 2023, 18:49 |
Societies
The EORTC 2022 Annual Report is out!
This comprehensive report collects the most relevant and up-to-date information on EORTC's activities, demonstrating the…
All:
39
Posts:
1 - 100
OncoDaily Forms Strategic Partnership with the National Foundation for Cancer Research (NFCR)
Hugh Jackman and Skin Cancer: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 4
34 Posts Not to Miss From ESMO24 Day 4
40 Posts Not To Miss From ESMO24 Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube